Wei Sun

This inventor holds 6 USPTO granted patents. Top assignees: University of Michigan, Sanofi, Ascenta Licensing Corporation. Active years: 2013-2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Wei Sun. Retrieved from https://idiyas.com/inventor/wei-sun-74ivfxwc

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 6

% Patents Active = 16.7

Average Co-Inventor Count = 4.1

ph-index = 3

Forward Citations = 29(Granted Patents)

Location History:

Ann Arbor, MI (US) (2013 - 2014)
Yunnan, CN (2014 - 2016)

Company Filing History:

6 out of 3,525

University of Michigan

Ascenta Licensing Corporation

patent

where one patent can have more than one assignee

Years Active: 2013-2016

Loading Chart...

6 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9302120 - Spiro-oxindole MDM2 antagonists (2016-04-05),

2. 9079913 - Spiro-oxindole MDM2 antagonists (2015-07-14),

3. 8877796 - Spiro-oxindole MDM2 antagonists (2014-11-04),

4. 8680132 - Spiro-oxindole MDM2 antagonists (2014-03-25),

5. 8629141 - Spiro-oxindole MDM2 antagonists (2014-01-14),

6. 8518984 - Spiro-oxindole MDM2 antagonists (2013-08-27),

Title: **The Innovations of Wei Sun: A Pioneer in Medicinal Chemistry**

Introduction

Wei Sun is an accomplished inventor based in Yunnan, China, with a remarkable portfolio of six patents. His work primarily revolves around the field of medicinal chemistry, focusing on innovative compounds that serve as potential therapeutic options for cancer treatment and other diseases.

Latest Patents

One of Wei Sun's notable recent patents includes the development of Spiro-oxindole MDM2 antagonists. These compounds and compositions are designed to inhibit the interaction between p53 and MDM2, aiming to provide therapeutic benefits in treating various diseases, particularly cancer. This breakthrough illustrates the significant impact of his research in advancing medicinal chemistry.

Career Highlights

Throughout his career, Wei Sun has made substantial contributions to pharmaceutical science, partnering with reputable organizations. Notably, he has worked at the University of Michigan and Sanofi, where he collaborated on groundbreaking research and innovative solutions in drug development.

Collaborations

Wei Sun's work has benefited from collaborations with esteemed colleagues such as Shaomeng Wang and Yujun Zhao. These partnerships have fostered a collaborative environment, enhancing the scope and impact of their collective research efforts.

Conclusion

In conclusion, Wei Sun stands out as a visionary inventor in the realm of medicinal chemistry. His contributions, particularly in the development of Spiro-oxindole MDM2 antagonists, showcase his commitment to innovation and his potential to transform therapeutic approaches to cancer and other serious illnesses.

Profile summary based on public USPTO records.

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]